Manufacturer profile

TriviumVet

Roxee groups catalog medications and public Innovation Watch records tied to this manufacturer, FDA sponsor, or disclosed development sponsor.

View Innovation Watch records All manufacturers

Veterinary professional?

Care category grouping

Where this maker appears in Roxee

No care category grouping has been assigned for this maker yet.

Medication catalog

0 catalog records

No public catalog records are grouped here yet

Roxee may still show Innovation Watch updates if public sponsor evidence exists.

Innovation Watch

2 public updates

Open filtered Innovation Watch

Development-stage products may not be FDA-approved, available, or proven safe/effective. Roxee only shows public evidence-backed stage labels.

Recently FDA-confirmed FDA-confirmed

LIAVIUM™-CA1

Species: Dogs
Condition: Pain & arthritis
Stage: FDA approved

LIAVIUM™-CA1 is indicated for the management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs.

View evidence

Recently FDA-confirmed FDA-confirmed

felycin-CA1

Species: Cats
Condition: Systemic hypertension
Stage: FDA approved

For the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM). Subclinical HCM refers to cats with left ventricular (LV) hypertrophy (LV wall thickness of ≥6 mm at end diasto...

View evidence